Changes in cystic fibrosis mortality in australia, 1979-2005

Medical Journal of Australia

Volumn 195, Issue 7, 2011, Pages 392-395

  Reid, David W ^a   Leigh Blizzard, C ^b   Shugg, Dace M ^b   Flowers, Ceri ^b   Cash, Catherine ^b   Greville, Hugh M ^c  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DEATH; FEMALE; HUMAN; INFANT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; SEX RATIO; SURVIVAL RATE; TREND STUDY; LIFE EXPECTANCY; MIDDLE AGED; PROGNOSIS;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; LIFE EXPECTANCY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84856396311     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja10.11229     Document Type: Article

References (31)

1. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29: 522-526.
2. Rosenfeld M, Davis R, FitzSimmons S, et al. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794-803.
3. Buchdahl R. Is there a gender gap in cystic fibrosis children? J R Soc Med 2007; 100 Suppl 47: 35-37.
4. Davis PB. The gender gap in cystic fibrosis survival. J Gend Specif Med 1999; 2: 47-51.
5. Kulich M, Rosenfeld M, Goss CH, Wilmott R. Improved survival among young patients with cystic fibrosis. J Pediatr 2003; 142: 631-636.
6. Lai HC, Kosorok MR, Laxova A, et al. Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol 2002; 156: 165-173.
7. Rawashdeh M, Manal H. Cystic fibrosis in Arabs: a prototype from Jordan. Ann Trop Paediatr 2000; 20: 283-286.
8. Verma N, Bush A, Buchdahl R. Is there still a gender gap in cystic fibrosis? Chest 2005; 128: 2824-2834.
9. Ketchell RI, Roughton M, Agent P, et al. Predicting survival in end-stage cystic fibrosis. Respir Med 2009; 103: 1441-1447.
10. Ramalle-Gomara E, Perucha M, González MA, et al. Cystic fibrosis mortality trends in Spain among infants and young children: 1981-2004. Eur J Epidemiol 2008; 23: 523-529.
11. Bellis G, et al. Cystic fibrosis mortality trends in France. J Cyst Fibros 2007; 6: 179-186.
12. Halliburton CS, Mannino DM, Olney RS. Cystic fibrosis deaths in the United States from 1979 through 1991. An analysis using multiple-cause mortality data. Arch Pediatr Adolesc Med 1996; 150: 1181-1185.
13. Fogarty A, Hubbard R, Britton J, et al. International comparison of median age at death from cystic fibrosis. Chest 2000; 117: 1656-1660.
14. Stern M, Wiedemann B, Wenzlaff P; German Cystic Fibrosis Quality Assessment Group. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 2008; 31: 29-35.
15. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation, patient registry annual data report 2005. Bethesda, Md: CFF, 2006.
16. United Kingdom Cystic Fibrosis Registry. UK CF Registry annual data report 2008. London: CF Trust, 2009.
17. Singer RB. Cystic fibrosis mortality: registry data of cystic fibrosis. J Insur Med 1997; 29: 233-239.
18. Phelan P, Hey E. Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80. Arch Dis Child 1984; 59: 71-73.
19. Australian Cystic Fibrosis Data Registry. Cystic fibrosis in Australia 2005. Annual report. Sydney: Cystic Fibrosis Australia, 2008. http://www.cysticfibrosis.org.au/pdf/Cystic_Fibrosis_in_Australia_2005.pdf (accessed Jun 2011).
20. Nick JA, Chacon CS, Brayshaw SJ. Effects of gender and age of diagnosis on disease progression in long-term cystic fibrosis survivors. Am J Respir Crit Care Med 2010; 182: 614-626.
21. O'Connor GT, Quinton HB, Kahn R, et al; Northern New England Cystic Fibrosis Consortium. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pedi a tr Pu lmo no l 2002; 33: 99-105.
22. Massie RJ, Olsen M, Glazner J, et al. New born screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Med J Aust 2000; 172: 584-587.
23. Massie J, Clements B; Australian Paediatric Respiratory Group. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience - twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005; 39: 440-446.
24. Grosse SD, Rosenfeld M, Devine OJ, et al. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 2006; 149: 362-366.
25. Allen JR, McCauley JC, Selby AM, et al. Differences in resting energy expenditure between male and female children with cystic fibrosis. J Pediatr 2003; 142: 15-19.
26. Festini F, Taccetti G, Campana S, et al. Gender differences in the acquisition of P. aeruginosa. Pediatr Pulmonol 2003; 36: 453-454; author reply 454.
27. Patterson JM, Wall M, Berge J, Milla C. Gender differences in treatment adherence among youth with cystic fibrosis: development of a new questionnaire. J Cyst Fibros 2008; 7: 154-164.
28. Casimir GJ, Mulier S, Hanssens L, et al. Chronic inflammatory diseases in children are more severe in girls. Shock 2010; 34: 23-26.
29. Truby H, Paxton AS. Body image and dieting behavior in cystic fibrosis. Pediatrics 2001; 107: E92.
30. Collins CE, O'Loughlin EV, Henry R. Discrepancies between males and females with cystic fibrosis in dietary intake and pancreatic enzyme use. J Pediatr Gastroenterol Nutr 1998; 26: 258-262.
31. Zemel BS, Kawchak DA, Cnaan A, et al. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis. Pediatr Res 1996; 40: 578-586.